Plasmacure

Plasmacure is a health care startup based in The Netherlands that focuses on revolutionizing chronic wound care. The company's patented cold plasma solution, PLASOMA, has proven to be 2.5x more effective in closing complex wounds compared to traditional methods in a randomized controlled trial. The solution, consisting of a 'pulser unit' and 'cold plasma pads', is CE-marked and has IP protection in the US, EU, UK, and CN. Plasmacure's technology not only improves patient outcomes but also presents significant cost-saving opportunities, with potential savings of over 40% in healthcare costs and 50% in staff workload. The company has been successful in scaling its operations in the Netherlands and selected markets and has garnered support from prominent investors such as NextGen Ventures, OostNL, and The European Economic Council. With the growing global demand for effective wound care solutions, Plasmacure presents an enticing opportunity for investors looking to contribute to the advancement of healthcare and make a meaningful impact on patient well-being.